This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hayakawa, T. Articles by Myoga, A. Search for Related Content PubMed PubMed Citation Articles by Hayakawa, T. Articles by Myoga, A.

Stroke, Vol 10, 685-689, Copyright © 1979 by American Heart Association

ARTICLES

Levels in stroke patients of CSF astroprotein, an astrocyte-specific cerebroprotein

T Hayakawa, Y Ushio, T Mori, N Arita, T Yoshimine, Y Maeda, K Shimizu and A Myoga

Astroprotein (an astrocyte-specific cerebroprotein) levels in cerebrospinal fluid (CSF) were determined by radioimmunoassay in 47 stroke patients. (Astroprotein is immunologically identical to glial fibrillary acidic protein.) Astroprotein levels in CSF increased markedly in acute cases of intracerebral hemorrhage and slightly to moderately in some acute cases of subarachnoid hemorrhage and cerebral infarction. In intracerebral hemorrhage, CSF astroprotein levels in the acute stage of the ictus reflected the size of the lesion and were used to estimate the clinical outcome. In subarachnoid hemorrhage and cerebral infarction, CSF astroprotein levels were related to the general neurological state. Evidence obtained indicated that fundamentally different destructive and/or degenerative processes in the brain may be involved in intracerebral hemorrhage, subarachnoid hemorrhage and cerebral infarction and that determination of CSF astroprotein may have clinical significance in stroke patients.

This article has been cited by other articles:

				F. E. Pfeiffer, H. A. Homburger, and T. Yanagihara Creatine Kinase BB Isoenzyme in CSF in Neurologic Diseases: Measurement by Radioimmunoassay Arch Neurol, March 1, 1983; 40(3): 169 - 172. [Abstract] [PDF]